The mineral density immediately below the surface of the tooth will lower if left unprotected to some extent.
| Group | Value | 95% CI |
|---|---|---|
| UDMA-K18 | 23.424 | ± 3.288 |
| UDMA-control | 31.125 | ± 4.275 |
| Adhesive Control | 35.563 | ± 7.378 |
Last reviewed · How we verify
Prevention of Enamel Demineralization by Use of K18-smooth Surface Sealant
NA trial testing UDMA-K18 smooth surface sealant in Dental Caries in 16 participants. Completed in 7 December 2018.
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 16 |
| Start date | 8 January 2018 |
| Primary completion | 7 December 2018 |
| Estimated completion | 7 December 2018 |
| Sites | 1 location across United States |
University of Colorado, Denver
Adults 12 to 89, any sex, with Dental Caries. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
The mineral density immediately below the surface of the tooth will lower if left unprotected to some extent.
| Group | Value | 95% CI |
|---|---|---|
| UDMA-K18 | 23.424 | ± 3.288 |
| UDMA-control | 31.125 | ± 4.275 |
| Adhesive Control | 35.563 | ± 7.378 |
The WSL Index is from 0 (no lesion) to 4 (severe lesion)
| Group | Value | 95% CI |
|---|---|---|
| UDMA-K18 | 0 | 0 – 2 |
| UDMA-control | 2 | 0 – 2 |
| Adhesive Control | 2 | 1 – 3 |
This study will evaluate effectiveness of a urethane dimethacrylate (UDMA)-quaternary ammonium methacrylate (K18) resin (UDMA-K18) smooth surface sealant to prevent biofilm attachment to tooth surfaces thereby eliminating the possibility for the tooth to be demineralized. The hypothesis is that UDMA-K18 containing smooth surface sealant will be more effective at reducing enamel demineralization than the UDMA control or no treatment.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03306433.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing